Vineti
Vineti was an enterprise software company for cell and gene therapy supply chain management, headquartered in San Francisco and founded in 2016. Its Personalized Therapy Management (PTM) platform — sold as PTM Enterprise and PTM Essentials — orchestrated the patient-centric supply chain behind autologous and allogeneic cell therapies, gene therapies and personalized cancer vaccines: chain of identity, chain of custody, apheresis and manufacturing scheduling, clinical-site workflows, and regulatory reporting. PTM was delivered as a configurable aPaaS on AWS, with HIPAA compliance certified by Avertium and GAMP-aligned validation. Vineti was named a World Economic Forum Technology Pioneer and raised a $35M Series C in 2020. The PTM software was acquired by Johnson & Johnson in 2023 to continue supporting its commercial therapy rollouts and clinical trials, and Vineti ceased to operate as an independent company: vineti.com no longer resolves and the domain now sits on Johnson & Johnson name servers. This profile is retained as a historical record — there is no live API surface to catalog.
Vineti is profiled on the APIs.io network. Tagged areas include Company, Cell and Gene Therapy, Life Sciences, Supply Chain, and Healthcare.
Kin Score
Resources
Build 1
SDKs, sample code, and the tooling you integrate with
Company 1
The organization behind the API